Alkemi welcomed Mitch DeKoven as Vice President, RWE and Evidence Strategy.
Public source
Publisher name
Public post
Please join us in welcoming Mitch DeKoven to Alkemi as Vice President, RWE and Evidence Strategy. Mitch brings 25 years of experience in RWE, HEOR, market access, reimbu…
Company
Alkemi
You deserve evidence that makes your treatment’s value undeniable.
- Industry
- Business Consulting and Services
- Location
- Cambridge, US
- Company size
- 11–50 employees
About Alkemi
HEOR & Market Access Consulting For Pharmaceutical & Life Sciences Companies
See moreLatest activity
Latest activity from Alkemi
3 signals
Discover more
Similar signals
Similar public activity from other companies.
People
ADVI Health
ADVI Health welcomed associate director Vi H. to the team bringing 10 years of cross-sector experience in drug pricing and market access to support biopharmaceutical clients.
People
Opus Regulatory Inc.
Opus Regulatory Inc. welcomed Zain Saleem to the Strategic Client Partnerships Director role at Opus Regulatory HQ.
People
Signum Life Science
Signum Life Science appointed Ulla Arthur Hvidtfeldt as Principal RWE Consultant with 15+ years in research and epidemiology from academia and the Danish Cancer Society.
People
Visible Analytics
Visible Analytics welcomed Anita Oseko as an Analyst in the Evidence Synthesis and Statistics team.
People
Nuvera Life Science Consulting